SG11201807616RA - Proliferative agent for faecalibacterium - Google Patents
Proliferative agent for faecalibacteriumInfo
- Publication number
- SG11201807616RA SG11201807616RA SG11201807616RA SG11201807616RA SG11201807616RA SG 11201807616R A SG11201807616R A SG 11201807616RA SG 11201807616R A SG11201807616R A SG 11201807616RA SG 11201807616R A SG11201807616R A SG 11201807616RA SG 11201807616R A SG11201807616R A SG 11201807616RA
- Authority
- SG
- Singapore
- Prior art keywords
- faecalibacterium
- proliferation
- vivo
- proliferative agent
- humans
- Prior art date
Links
- 241001608234 Faecalibacterium Species 0.000 title abstract 6
- 230000002062 proliferating effect Effects 0.000 title abstract 2
- 230000035755 proliferation Effects 0.000 abstract 4
- 238000001727 in vivo Methods 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- VAWYEUIPHLMNNF-OESPXIITSA-N 1-kestose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VAWYEUIPHLMNNF-OESPXIITSA-N 0.000 abstract 1
- GIUOHBJZYJAZNP-DVZCMHTBSA-N 1-kestose Natural products OC[C@@H]1O[C@](CO)(OC[C@]2(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O GIUOHBJZYJAZNP-DVZCMHTBSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- VAWYEUIPHLMNNF-UHFFFAOYSA-N kestotriose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 VAWYEUIPHLMNNF-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016049586 | 2016-03-14 | ||
| PCT/JP2017/010070 WO2017159647A1 (fr) | 2016-03-14 | 2017-03-14 | Agent prolifératif pour des bactéries du genre faecalibacterium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201807616RA true SG11201807616RA (en) | 2018-10-30 |
Family
ID=59851477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201807616RA SG11201807616RA (en) | 2016-03-14 | 2017-03-14 | Proliferative agent for faecalibacterium |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190070204A1 (fr) |
| EP (1) | EP3431090A4 (fr) |
| JP (1) | JP6301024B2 (fr) |
| KR (1) | KR20180122380A (fr) |
| CN (1) | CN109069521A (fr) |
| PH (1) | PH12018501989A1 (fr) |
| SG (1) | SG11201807616RA (fr) |
| WO (1) | WO2017159647A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10874680B2 (en) | 2017-09-25 | 2020-12-29 | Tata Chemicals Limited | Method of increasing relative abundance of oscillospira |
| JP6842072B2 (ja) * | 2019-03-07 | 2021-03-17 | 物産フードサイエンス株式会社 | エガセラ属細菌の菌数抑制剤 |
| US20240041949A1 (en) | 2020-12-09 | 2024-02-08 | Meiji Co., Ltd. | Composition comprising bacterium of the genus acidipropionibacterium or processed product thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11503168A (ja) * | 1995-04-05 | 1999-03-23 | アボツト・ラボラトリーズ | 非消化性オリゴ糖によるＣ．ｄｉｆｆｉｃｉｌｅ感染の抑制 |
| JP2004049093A (ja) * | 2002-07-18 | 2004-02-19 | Meiji Milk Prod Co Ltd | 腸内酪酸上昇食品組成物および医薬品 |
| US20050119222A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use |
| US20050118299A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Companion animal compositions comprising short chain oligofructose |
| JP4669235B2 (ja) * | 2004-04-21 | 2011-04-13 | ホクレン農業協同組合連合会 | 腸内環境下ビフィズス菌増殖剤 |
| JP4162147B2 (ja) * | 2005-04-21 | 2008-10-08 | ホクレン農業協同組合連合会 | アレルギー抑制剤 |
| JPWO2007043563A1 (ja) * | 2005-10-13 | 2009-04-16 | 明治製菓株式会社 | 腸内フローラ改善用組成物 |
| JP2012176907A (ja) * | 2011-02-25 | 2012-09-13 | Glico Dairy Products Co Ltd | フラクトオリゴ糖を有効成分とするミオシン軽鎖脱リン酸化促進剤、疾患の予防又は治療剤、及び飲食品 |
| BR112014010660A2 (pt) * | 2011-11-04 | 2017-05-09 | Gen Mills Inc | métodos e composições para modular bactéria gastrointestinal |
| JP5921894B2 (ja) * | 2012-01-20 | 2016-05-24 | アサヒカルピスウェルネス株式会社 | 腸内酪酸産生菌増加剤 |
-
2017
- 2017-03-14 CN CN201780017016.5A patent/CN109069521A/zh active Pending
- 2017-03-14 WO PCT/JP2017/010070 patent/WO2017159647A1/fr active Application Filing
- 2017-03-14 EP EP17766646.8A patent/EP3431090A4/fr not_active Withdrawn
- 2017-03-14 US US16/084,380 patent/US20190070204A1/en not_active Abandoned
- 2017-03-14 JP JP2017549363A patent/JP6301024B2/ja active Active
- 2017-03-14 SG SG11201807616RA patent/SG11201807616RA/en unknown
- 2017-03-14 KR KR1020187028413A patent/KR20180122380A/ko not_active Application Discontinuation
-
2018
- 2018-09-14 PH PH12018501989A patent/PH12018501989A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2017159647A1 (ja) | 2018-03-22 |
| US20190070204A1 (en) | 2019-03-07 |
| KR20180122380A (ko) | 2018-11-12 |
| WO2017159647A1 (fr) | 2017-09-21 |
| CN109069521A (zh) | 2018-12-21 |
| PH12018501989A1 (en) | 2019-06-24 |
| EP3431090A1 (fr) | 2019-01-23 |
| EP3431090A4 (fr) | 2020-04-15 |
| JP6301024B2 (ja) | 2018-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021013830A (es) | Inhibidores de ezh2 para tratar linfomas. | |
| PH12018501988A1 (en) | Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria | |
| MX2016007351A (es) | Terapia de combinacion para tratar cancer. | |
| MX2019010601A (es) | Terapia de combinacion para tratar cancer. | |
| EA201992722A1 (ru) | N2,n4-дифенилпиримидин-2,4-диаминовое производное, способ его получения и фармацевтическая композиция, содержащая его в качестве активного ингредиента, для профилактики и лечения рака | |
| MX2017012426A (es) | Composiciones y metodos para modular la expresion de tmprss6. | |
| WO2016025635A3 (fr) | Polythérapie pour le traitement du cancer | |
| MX2021006734A (es) | Metodo para tratar el cancer. | |
| MX2017013142A (es) | Terapia combinada para tratar cáncer. | |
| MX2015010791A (es) | Metodos para tratar el cancer y prevenir la resistencia a farmacos. | |
| MX2022014634A (es) | Metodos para la administracion linfatica de agentes activos. | |
| EP3639833A4 (fr) | Agent pour la prévention ou le traitement de maladies liées à la graisse et/ou de l'inflammation | |
| CY1122968T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει μια ενωση διαμινο-ετεροκυκλικου καρβοξαμιδιου ως δραστικο συστατικο | |
| MX365366B (es) | Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné. | |
| PH12018501989A1 (en) | Proliferative agent for faecalibacterium | |
| PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
| MX2017011018A (es) | Inhibicion de la actividad de olig2. | |
| MX2017014456A (es) | Usos terapeuticos de l-4-cloroquinurenina. | |
| ZA201901367B (en) | Inhibition of olig2 activity | |
| MX2018008640A (es) | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano. | |
| MX2020008275A (es) | Metodos para tratar trastornos mitocondriales. | |
| EP3643302C0 (fr) | Composition comprenant un dérivé de sesquiterpène en tant que principe actif pour la prévention ou le traitement de maladies musculaires | |
| IN2015KN00370A (fr) | ||
| EA201992234A1 (ru) | Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента | |
| GB2550750A (en) | Anthelmintic compounds |